Creighton professor to lead NIH pain research project
A Creighton professor will lead a multi-university team of researchers charged with finding pain therapies that will reduce the need for highly addictive opioids.
Shashank Dravid, PhD, an associate professor of pharmacology and neuroscience at the Creighton University School of Medicine, brings his expertise in both disciplines to the wide-ranging assault on opioids that is the focus of a five-year $2.7 million grant from the National Institutes of Health.
A project summary published by the NIH states that pain impacts more than 100 million Americans, costing several hundred billion dollars in health care costs and lost productivity.
“Persistent pain may produce long-term disability and lead to precipitation of depression, anxiety and cognitive impairment,” the summary said. “Currently used medications for chronic pain are not always effective and have limitations in terms of tolerance and abuse liability. Thus, identifying novel therapeutic targets is essential to address this clinical burden.”